⌘K

Login Start Free

Home/Filings/4/0001179110-17-012323

4//SEC Filing

BARROWS CRAIG 4

Accession 0001179110-17-012323

CIK 0000855654other

View on SEC.gov Company Profile

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 3:51 PM ET

Size

12.9 KB

Accession

0001179110-17-012323

Insider Transaction Report

Form 4

Period: 2017-09-13

IMMUNOGEN INCIMGN

Vice-President,General Counsel

Transactions

Sale
Common Stock
2017-09-13$6.95/sh−14,600$101,404→ 36,500 total
Sale
Common Stock
2017-09-15$6.73/sh−22,450$151,053→ 44,050 total
Exercise/Conversion
Common Stock
2017-09-13$4.50/sh+20,000$90,000→ 51,100 total
Exercise/Conversion
Common Stock
2017-09-15$4.50/sh+30,000$135,000→ 66,500 total
Exercise/Conversion
Stock Option (right to buy)
2017-09-13$4.50/sh−20,000$90,000→ 30,000 total
Exercise: $4.50From: 2008-10-03Exp: 2017-10-03→ Common Stock (20,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-09-15$4.50/sh−30,000$135,000→ 0 total
Exercise: $4.50From: 2008-10-03Exp: 2017-10-03→ Common Stock (30,000 underlying)

Footnotes (2)

[F1]Exercisable as to 12,500 shares commencing on October 3, 2008, 12,500 shares commencing on October 3, 2009, 12,500 shares commencing on October 3, 2010 and 12,500 shares commencing on October 3, 2011.
[F2]Weighted average price of shares sold.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

IMMUNOGEN INC

CIK 0000855654

Entity typeother

Related Parties

1

filerCIK 0001177813

Filing Metadata

Form type: 4
Filed: Sep 14, 8:00 PM ET
Accepted: Sep 15, 3:51 PM ET
Size: 12.9 KB

View on SEC.gov